Save B32SP High&Low Molecule HA+Succine Acid

Shopping Event
· Get more discount for bulk from 5 pcs

· Free shipping over 1500$

Save B32SP combines hyaluronic acid with 3% succinic acid to visibly rejuvenate aging hands. Its fast-acting formula instantly boosts glow (+29.6% luminosity in 30 minutes) while stimulating long-term collagen growth (+42% in clinical trials). Ideal for sun-damaged skin and volume loss, results last up to 6 months.

$62.00

Quantity discounts
Quantity Discount Price
5-9 4% $59.52
10-19 8% $57.04
20-Unlimited 10% $55.80

Save B32SP High&Low Molecule HA+Succinic Acid

Save B32SP combines 3% Succinic Acid (JCRD-certified mitochondrial ATPase activator, +217% activity) with dual-weight hyaluronic acid for cellular-level rejuvenation. Clinical data (n=120) demonstrates 42% increased collagen synthesis in fibroblasts, specifically formulated for hand volume restoration and photoaging reversal. Complies with ISO 13485:2016 medical device standards.

Metabolic Activation

Succinic acid inhibits MMP-1 activity by 68.3% while boosting ATP production 2.17x baseline.

Synergistic Release

HA-Succinate complex ensures pH 7.4-controlled release over 72 hours.

Instant Refinement

29.6% immediate skin luminosity improvement (Cutometer® MPA580 verified).

Core Technology
  • Smart Release® nanosphere technology with PLGA carriers
  • Precision particle sizing (20-50μm D90 distribution) for mid-dermal delivery
  • Dual-phase viscosity modulation (G’ 250-300Pa at 25℃)

Packaging Specifications

Contents: 1.2ml/syringe × 8 units/box

Needles: 25G sharp needles (individually sealed)

Closure: EPFR rubber stopper (≥20 punctures leakage-free)

Storage: 2-8°C protected from light. Do not freeze.

Shelf Life: 18 months unopened

Clinical Protocols
Hand Augmentation

Fan technique: 10 injection points (0.05ml/point)

Depth Control

Deep dermal-subcutaneous junction (30° needle angle)

Contraindications

Avoid concurrent vitamin C derivatives (pH incompatibility risk)

Important Notice

Individual results may vary based on tissue characteristics and injection technique. CFDA adverse reaction rate: <0.33% (2023 data).

For use only by licensed practitioners with Class III implantable device certification (NMPA Registration: 2023345XXXX).

Post-treatment: Avoid radiofrequency devices for 48 hours. Maintain cold chain during transport (2-8°C).

0 reviews
0
0
0
0
0

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Interested in Wholesale?

Contact Us Now

Be The First To Know About Wholesale, Exclusive Sales & More

Interested in Wholesale?

Contact Us Now

Be The First To Know About Wholesale, Exclusive Sales & More